BRITTANY D'AMICO: Open Payments
NPI 1376190538 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,394 in 137 payments from 18 companies in 2025. Trend: 2023 $1,789 · 2024 $2,158 · 2025 $3,394
Food & beverage: $3,309Education: $85
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 32 | $1,096 |
| ABBVIE INC. | 26 | $449 |
| Galderma Laboratories, L.P. | 19 | $344 |
| Regeneron Healthcare Solutions, Inc. | 7 | $212 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $200 |
| Lilly USA, LLC | 5 | $195 |
| Janssen Biotech, Inc. | 10 | $182 |
| Incyte Corporation | 7 | $154 |
| GENZYME CORPORATION | 4 | $133 |
| PFIZER INC. | 5 | $124 |
Products named: ANZUPGO, ADBRY, DUPIXENT, RINVOQ, TREMFYA, AKLIEF, Winlevi, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
